- Home
- IMA vs ZURA Comparison
IMA vs ZURA Comparison
Compare IMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- ZURA
- Stock Information
- Founded
- IMA 2019
- ZURA 2022
- Country
- IMA United States
- ZURA United States
- Employees
- IMA N/A
- ZURA N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMA Health Care
- ZURA Health Care
- Exchange
- IMA Nasdaq
- ZURA Nasdaq
- Market Cap
- IMA 69.5M
- ZURA 69.9M
- IPO Year
- IMA N/A
- ZURA N/A
- Fundamental
- Price
- IMA N/A
- ZURA $1.50
- Analyst Decision
- IMA
- ZURA Buy
- Analyst Count
- IMA 0
- ZURA 7
- Target Price
- IMA N/A
- ZURA $14.33
- AVG Volume (30 Days)
- IMA 45.7K
- ZURA 990.1K
- Earning Date
- IMA 01-01-0001
- ZURA 08-15-2025
- Dividend Yield
- IMA N/A
- ZURA N/A
- EPS Growth
- IMA N/A
- ZURA N/A
- EPS
- IMA N/A
- ZURA N/A
- Revenue
- IMA N/A
- ZURA N/A
- Revenue This Year
- IMA N/A
- ZURA N/A
- Revenue Next Year
- IMA N/A
- ZURA N/A
- P/E Ratio
- IMA N/A
- ZURA N/A
- Revenue Growth
- IMA N/A
- ZURA N/A
- 52 Week Low
- IMA $11.65
- ZURA $0.97
- 52 Week High
- IMA $23.28
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- ZURA 53.14
- Support Level
- IMA N/A
- ZURA $1.60
- Resistance Level
- IMA N/A
- ZURA $1.75
- Average True Range (ATR)
- IMA 0.00
- ZURA 0.19
- MACD
- IMA 0.00
- ZURA -0.03
- Stochastic Oscillator
- IMA 0.00
- ZURA 26.09
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.